Temasek Holdings-backed Accuron MedTech has completed the divestment of its shares in molecular detection tests provider Veredus Laboratories to Japan-based diagnostics company SEKISUI MEDICAL, a subsidiary of SEKISUI CHEMICAL Co., Ltd.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
